VC Spotlight: Tau Ventures

In conversation with Amit Garg

Tau Ventures was never meant to chase trends. It was built to anticipate them.

When Amit Garg and his co-founder Sanjay Rao launched Tau Ventures in Silicon Valley, they were acting on nearly a decade of shared conviction. Having worked together for years and debated where technology and society were headed, they arrived at a clear conclusion: artificial intelligence would fundamentally reshape healthcare and enterprise, and early-stage venture capital would need to evolve with it.

Today, Tau Ventures manages just about $100 million across multiple funds and vehicles, backing AI-first companies at the seed stage. But the numbers tell only part of the story. What distinguishes Tau is a philosophy rooted in long-term value creation, deep partnership with founders, and a belief that technology exists to serve people.

Tau Ventures – An AI-First Fund with a Human-Centered Mission

Tau Ventures is an early-stage venture capital firm headquartered in Silicon Valley, managing capital across Fund I, Fund II, an opportunity fund, and several SPVs. From the beginning, it has been explicitly AI-first, with a core focus on digital health and enterprise.

For Garg, the excitement around AI is not abstract. In the U.S., healthcare has become the fastest industry to adopt AI, outpacing nearly every other sector. Tau-backed companies use computer vision to detect cancer, machine learning to accelerate drug discovery, and AI-driven systems to simplify billing, payments, scheduling, and price transparency. Others help patients navigate the healthcare system itself, empowering decisions on where to go, who to see, and what care they actually need.

At its core, this is about quality of life. “Technology is here to serve people,” Garg says, “not the other way around.” AI, in his view, is not just a productivity tool, it is a mechanism to make healthcare more humane, more accessible, and more rational.

Investing Amid Economic and Geopolitical Uncertainty

The backdrop to today’s venture market is unmistakably volatile: geopolitical tensions, uneven economic recovery, and shifting capital cycles. Tau’s response, however, has been grounded in discipline rather than reaction.

The firm focuses primarily on seed-stage investing, which Garg defines not by labels but by purpose: capital used to reach a minimum viable product and early traction. It’s beyond a pitch deck, but not yet product-market fit. In the U.S., that typically translates to seed rounds of $4–5 million.

Tau currently writes initial checks of around $500,000, reserving roughly 50% for follow-on investments. The firm reviews approximately 6,000 deals a year and invests in about 12 per year, roughly one each month. That level of selectivity reflects both caution and conviction.

Sector focus plays a key role in resilience. Healthcare alone accounts for roughly 18–20% of U.S. GDP, or about $4.6 trillion annually. Astonishingly, nearly one-third of that spend—around $1.6 trillion—goes to administrative overhead. For Garg, this inefficiency is not cyclical; it’s structural. Regardless of political or economic shifts, the need to make healthcare more efficient and outcomes-driven is unavoidable.

In addition, Tau invests in startups focused on AI for cybersecurity, infrastructure, fintech, and robotics.

How Tau’s Strategy Has Evolved—Internally and Externally

Tau’s evolution mirrors its growth. What began as a two-person partnership with a $17 million debut fund has grown into a five-person full-time team, supported by venture partners, advisors, and a broad global community.

That expansion has changed how Tau invests. Early checks of $250,000 have grown to $500,000, with plans to go higher. More importantly, the firm’s role has deepened. Tau has always believed in being an active partner, helping founders not only with capital, but with customers, talent, and follow-on investors.

Its network is a core asset: more than 5000 industry professionals receive Tau’s monthly communications, while an extensive advisory ecosystem connects founders to CEOs, CIOs, CISOs, and other decision-makers. This catalyses partnerships, contracts, and even acquisitions.

Externally, the firm has adapted to shocks like COVID, political transitions, and macroeconomic tightening. One metric has remained constant, which is helping portfolio companies with introductions to other investors and customers, and maintain at least 12 months of runway. The goal is to keep companies alive and growing to win.

Value Chains, Falling Barriers, and the New Importance of Distribution

Garg’s perspective on value chain evolution is deeply personal. Trained in computer science and biology at Stanford, with a master’s degree in biomedical informatics, he has lived at the intersection of technology and healthcare for decades. His career spans Google’s early years, Harvard Business School, venture capital, and startup founding.

The most profound shift he observes is that technology is no longer the bottleneck.

Twenty-five years ago, building a startup meant building the stack from scratch. Today, cloud platforms, APIs, app stores, and no-code or “vibe coding” tools have dramatically lowered the barrier to entry. You no longer need to be a software engineer to build a tech company.

This has democratized entrepreneurship, but it has also shifted the battlefield. If creation is easier, scaling is harder. Distribution, in terms of access to customers, attention, and sustained engagement, has become the defining challenge.

At Tau, this has recalibrated priorities. While team remains paramount, traction increasingly outweighs pure technology. The firm evaluates every opportunity through its three Ts: team, technology, and traction with distribution now central to long-term success.

Priority Sectors and the Rise of Non-Linear Growth

Tau’s investment focus reflects both specialization and balance. Garg leans heavily into digital health, while Rao emphasizes enterprise; the broader team spans both.

What excites Garg most in healthcare is the pace of AI adoption, which is growing at roughly double the rate of the broader U.S. economy. Rising costs, labor shortages, and system complexity have made AI not optional, but necessary.

This shift has unlocked new business models. Traditional growth heuristics like the famed “triple, triple, double, double” are being eclipsed. AI-native companies are now achieving unprecedented quadruple, quadruple, triple, triple growth trajectories.

The implication is clear: the winners are scaling faster than ever before. While scaling remains difficult, those who succeed do so with extraordinary velocity, even in sectors like healthcare that were once considered slow-moving.

Investment Themes: Geography Matters, Teams Matter More

Access to capital, talent, and networks remains uneven, and Silicon Valley is still the epicenter. Roughly half of U.S. venture capital flows through the region, and many of the largest AI breakthroughs originate there.

Tau leverages this advantage, but does not confine itself to it. About half of its investments are outside Silicon Valley. In healthcare especially, innovation follows population, not prestige. Tau backs companies in places like Dallas, Wisconsin, North Carolina, and other nontraditional hubs.

Whether innovation is incremental or disruptive, capital-rich or capital-constrained, one factor dominates every decision: the team. If the team is strong, Tau will partner with them and help navigate whatever obstacles lie ahead.

Collaboration as a Core Operating Principle

At the seed stage, venture capital is fundamentally collaborative. Tau strongly believes in syndicates with a clear lead and a small number of supportive co-investors enough to diversify expertise without overwhelming founders.

Tau often plays the role of the second or third investor, though it aims to lead more rounds in the future. Garg himself speaks with multiple VCs daily, exchanging insights, pressure-testing ideas, and building long-term trust.

Some of these relationships span decades. For Garg, cooperation isn’t just good investing, it’s foundational to progress itself. As he notes, humanity advanced not because of competition alone, but because of its ability to collaborate.

Lessons from Success and from the Journey Itself

Success, Garg explains, is easier to explain in hindsight. Tau has backed over 80 portfolio companies, almost 100% of which have raised follow-on capital, including:

• A $10.6B acquisition
• A $2.1B IPO
• A $190M acquisition
• 17x and 14x+ returns
• A unicorn (~$1B valuation)

One standout example is Iterative Health, Tau’s first investment in 2019 and now one of the firm’s most outsized successes. Tau was its first U.S. VC investor and helped bring in customers and later-stage capital.

At the center of Iterative Health’s story is its founder and CEO, Jonathan Ng, a visionary entrepreneur building in the U.S. Garg attributes much of the company’s success to Ng’s relentless drive and ability to inspire teams and investors alike.

Earlier, Ng secured access to tens of thousands of sensitive medical videos from dozens of hospitals to train AI models, which is an extraordinary feat for an unknown startup. As AI capabilities matured, Iterative Health evolved its business model, expanding into clinical trials and patient matching while integrating seamlessly into healthcare workflows.

Adaptability proved critical. The company weathered COVID, revenue fluctuations, and organizational changes by remaining agile. In Garg’s view, evolution favors those most willing to adapt, and adapt quickly.

The Future of Venture Capital: Why Seed Investing Remains Human

The possibility that venture capital may be replaced by algorithms has been highlighted. Garg believes parts of the industry, particularly late-stage investing, will become increasingly data-driven, resembling hedge funds in their reliance on models and metrics.

But at the seed stage, the data simply isn’t there.

Early investing is about trust, relationships, vision, and co-creation. These are not easily reducible to spreadsheets or LLM outputs. While Tau actively uses AI tools in its own work, Garg is confident that algorithms will not replace seed investors anytime soon. “My job is safe for a while,” he jokes while the sentiment is serious. AI is powerful, but at the earliest stages of company building, people still matter most.

A Long-Term Bet on People, not just Technology

Tau Ventures’ story is ultimately not about chasing AI, it’s about understanding how AI reshapes industries, incentives, and human behavior. By pairing technical conviction with market potential, collaborative strength and deep founder partnership, Amit Garg and his team are building a Venture Capital fund that is determined to shape a better future.